Evidence map›Paper›PMID 35384749›Full record

ArticleJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics2022

Topical Porphyrin Antioxidant Protects Against Ocular Surface Pathology in a Novel Rabbit Model for Particulate Matter-Induced Dry Eye Disease.

Anita Kirti Ghosh, Marianna Bacellar-Galdino, Sana Iqbal, Nathaniel E Pappenhagen, Simon Kaja

Open access · greenAbstract read
In one paragraph

Article in Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Dietary Alcohol Consumption Elicits Corneal Toxicity Through the Generation of Cellular Oxidative Stress.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Anita Kirti GhoshGraduate Program in Biochemistry and Molecular Biology, Loyola University Chicago, Maywood, Illinois, USA.
Marianna Bacellar-GaldinoResearch & Development Division, Experimentica Ltd., Forest Park, Illinois, USA.
Sana IqbalVisual Neurobiology and Signal Transduction Laboratory, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA.
Nathaniel E PappenhagenResearch & Development Division, Experimentica Ltd., Forest Park, Illinois, USA.
Simon KajaVisual Neurobiology and Signal Transduction Laboratory, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA.ORCID 0000-0001-6878-521X
Forest Research · GBLoyola University Chicago · USUniversity of North Texas · US

Funding

Immunotherapy for Ocular Surface DiseasesR24EY032440 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI JAIN, SANDEEP · 2021 to 2025
$8.3M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ConjunctivitisDry Eye SyndromesHyperemiaPorphyrinsAnimalsAntioxidantsCorneaDisease Models, AnimalFluoresceinOphthalmic SolutionsParticulate MatterRabbitsTearsAntioxidantsFluoresceinOphthalmic SolutionsParticulate MatterPorphyrinsantioxidantconjunctivitiscorneadry eyelifitegrastmanganese porphyrinocular surface disease

Identifiers

PMID35384749
PMCPMC9125571
OpenAlexW4225435599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.